Glutamate mechanisms underlying opiate memories

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 9, 2012, Pages

  Peters, Jamie ^a   De Vries, Taco J ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; CYCLOSERINE; DIAMORPHINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMIC ACID; IFENPRODIL; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 5; MODAFINIL; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NALOXONE; DOPAMINE RECEPTOR;

AMYGDALOID NUCLEUS; ARTICLE; AVERSION; BEHAVIOR; CONDITIONED REWARD; DOPAMINERGIC SYSTEM; DRUG SEEKING BEHAVIOR; HIPPOCAMPUS; HUMAN; MEMORY; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE ADDICTION; PREFRONTAL CORTEX; REINFORCEMENT; REINSTATEMENT; CONDITIONING; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; REWARD;

AMYGDALA; CONDITIONING (PSYCHOLOGY); EXTINCTION, PSYCHOLOGICAL; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; MEMORY; NUCLEUS ACCUMBENS; OPIOID-RELATED DISORDERS; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT (PSYCHOLOGY); REWARD;

EID: 84879304011     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a012088     Document Type: Article

References (125)

1. Aoki T, Narita M, Shibasaki M, Suzuki T. 2004. Metabotropic glutamate receptor 5 localized in the limbic forebrain is critical for the development of morphine-induced rewarding effect in mice. Eur J Neurosci 20: 1633-1638.
2. Badiani A, Belin D, Epstein D, Calu D, Shaham Y. 2011. Opiate versus psychostimulant addiction: The differences do matter. Nat Rev Neurosci 12: 685-700.
3. Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, Kalivas PW. 2003. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6: 743-749.
4. Billa SK, Sinha N, Rudrabhatla SR, Moron JA. 2009. Extinction of morphine-dependent conditioned behavior is associated with increased phosphorylation of the GluR1 subunit of AMPA receptors at hippocampal synapses. Eur J Neurosci 29: 55-64.
5. Bishop SF, Lauzon NM, Bechard M, Gholizadeh S, Laviolette SR. 2011. NMDA receptor hypofunction in the prelimbic cortex increases sensitivity to the rewarding properties of opiates via dopaminergic and amygdalar substrates. Cereb Cortex 21: 68-80.
6. Blokhina EA, Sukhotina IA, Bespalov AY. 2000. Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: Effects of NMDA receptor antagonists. Eur J Pharmacol 406: 227-232.
7. Bossert JM, Liu SY, Lu L, Shaham Y. 2004. A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J Neurosci 24: 10726-10730.
8. Bossert JM, Busch RF, Gray SM. 2005a. The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking. Neuroreport 16: 1013-1016.
9. Bossert JM, Ghitza UE, Lu L, Epstein DH, Shaham Y. 2005b. Neurobiology of relapse to heroin and cocaine seeking: An update and clinical implications. Eur J Pharmacol 526: 36-50.
10. Bossert JM, Gray SM, Lu L, Shaham Y. 2006. Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking. Neuropsychopharmacology 31: 2197-2209.
11. Bossert JM, Poles GC, Wihbey KA, Koya E, Shaham Y. 2007. Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues. J Neurosci 27: 12655-12663.
12. Bossert JM, Stern AL, Theberge FR, Cifani C, Koya E, Hope BT, Shaham Y. 2011. Ventral medial prefrontal cortex neuronal ensembles mediate context-induced relapse to heroin. Nat Neurosci 14: 420-422.
13. Bossert JM, Stern AL, Theberge FR, Marchant NJ, Wang HL, Morales M, ShahamY. 2012. Role of projections from ventral medial prefrontal cortex to nucleus accumbens shell in context-induced reinstatement of heroin seeking. J Neurosci 32: 4982-4991.
14. Carlezon WA Jr., Boundy VA, Haile CN, Lane SB, Kalb RG, Neve RL, Nestler EJ. 1997. Sensitization to morphine induced by viral-mediated gene transfer. Science 277: 812-814.
15. Carlezon WA Jr., Haile CN, Coppersmith R, Hayashi Y, Malinow R, Neve RL, Nestler EJ. 2000. Distinct sites of opiate reward and aversion within the midbrain identified using a herpes simplex virus vector expressing GluR1. J Neurosci 20: RC62.
16. Comer SD, Sullivan MA. 2007. Memantine produces modest reductions in heroin-induced subjective responses in human research volunteers. Psychopharmacology (Berl) 193: 235-245.
17. Corrigall WA, Linseman MA. 1988. Conditioned place preference produced by intra-hippocampal morphine. Pharmacol Biochem Behav 30: 787-789.
18. Davis M, Ressler K, Rothbaum BO, Richardson R. 2006. Effects of D-cycloserine on extinction: Translation from preclinical to clinical work. Biol Psychiatry 60: 369-375.
19. Di Ciano P, Everitt BJ. 2004. Direct interactions between the basolateral amygdala and nucleus accumbens core underlie cocaine-seeking behavior by rats. J Neurosci 24: 7167-7173.
20. Eisch AJ, Barrot M, Schad CA, Self DW, Nestler EJ. 2000. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci 97: 7579-7584.
21. Emmers R. 1985. Stimulation of the periaqueductal gray subdues sensitized pain in morphine-and meperidine-dependent rats. Exp Neurol 88: 405-417.
22. Fatseas M, Denis C, Massida Z, Verger M, Franques-Reneric P, Auriacombe M. 2011. Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals. Biol Psychiatry 70: 720-727.
23. Floresco SB, Yang CR, Phillips AG, Blaha CD. 1998. Basolateral amygdala stimulation evokes glutamate receptor-dependent dopamine efflux in the nucleus accumbens of the anaesthetized rat. Eur J Neurosci 10: 1241-1251.
24. Floresco SB, Blaha CD, Yang CR, Phillips AG. 2001. Dopamine D1 and NMDA receptors mediate potentiation of basolateral amygdala-evoked firing of nucleus accumbens neurons. J Neurosci 21: 6370-6376.
25. Fujio M, Nakagawa T, Sekiya Y, Ozawa T, Suzuki Y, Minami M, Satoh M, KanekoS. 2005. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine-and morphine-induced conditioned place preference in rats. Eur J Neurosci 22: 2744-2754.
26. Glass MJ, Hegarty DM, Oselkin M, Quimson L, South SM, Xu Q, Pickel VM, Inturrisi CE. 2008. Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice. Exp Neurol 213: 57-70.
27. Harris GC, Aston-Jones G. 2003. Enhanced morphine preference following prolonged abstinence: Association with increased Fos expression in the extended amygdala. Neuropsychopharmacology 28: 292-299.
28. Harris GC, Aston-Jones G. 2007. Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal. Behav Brain Res 176: 251-258.
29. Harris GC, Wimmer M, Byrne R, Aston-Jones G. 2004. Glutamate-associated plasticity in the ventral tegmental area is necessary for conditioning environmental stimuli with morphine. Neuroscience 129: 841-847.
30. He YY, Xue YX, Wang JS, Fang Q, Liu JF, Xue LF, Lu L. 2011. PKMζ maintains drug reward and aversion memory in the basolateral amygdala and extinction memory in the infralimbic cortex. Neuropsychopharmacology 36: 1972-1981.
31. Heinmiller A, Ting AKR, Vargas-Perez H, Yeh A, van der Kooy D. 2009. Tegmental pedunculopontine glutamate and GABA-B synapses mediate morphine reward. Behav Neurosci 123: 145-155.
32. Herman BH, Vocci F, Bridge P. 1995. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction. Neuropsychopharmacology 13: 269-293.
33. Herzig V, Schmidt WJ. 2004. Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine. Neuropharmacology 47: 973-984.
34. Hou YY, Liu Y, Kang S, Yu C, Chi ZQ, Liu JG. 2009. Glutamate receptors in the dorsal hippocampus mediate the acquisition, but not the expression, of conditioned place aversion induced by acute morphine withdrawal in rats. Acta Pharmacol Sin 30: 1385-1391.
35. Jacobs EH, Smit AB, de Vries TJ, Schoffelmeer AN. 2005. Long-term gene expression in the nucleus accumbens following heroin administration is subregion-specific and depends on the nature of drug administration. Addict Biol 10: 91-100.
36. Jacquet YF. 1988. The NMDA receptor: Central role in pain inhibition in rat periaqueductal gray. Eur J Pharmacol 154: 271-276.
37. Jalabert M, Bourdy R, Courtin J, Veinante P, Manzoni OJ, Barrot M, Georges F. 2011. Neuronal circuits underlying acute morphine action on dopamine neurons. Proc Natl Acad Sci 108: 16446-16450.
38. Kalivas PW. 2009. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10: 561-572.
39. Kao JH, Huang EY, Tao PL. 2011. NR2B subunit of NMDA receptor at nucleus accumbens is involved in morphine rewarding effect by siRNA study. Drug Alcohol Depend 118: 366-374.
40. Kawasaki Y, Jin C, Suemaru K, Kawasaki H, Shibata K, Choshi T, Hibino S, Gomita Y, Araki H. 2005. Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats. Br J Pharmacol 145: 751-757.
41. Kawasaki Y, Ishida S, Jin C, Kitamura Y, Kawasaki H, Gomita Y, Sendo T, ArakiH. 2011. Effect of glutamate receptor antagonists microinjected into the nucleus accumbens on place aversion induced by naloxone in single-dose, morphine-treated rats. Eur J Pharmacol 666: 131-134.
42. Krupitsky E, Burakov A, Romanova T, Dunaevsky I, Strassman R, Grinenko A. 2002. Ketamine psychotherapy for heroin addiction: Immediate effects and two-year follow-up. J Subst Abuse Treat 23: 273-283.
43. LaLumiere RT, Kalivas PW. 2008. Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci 28: 3170-3177.
44. LaRowe SD, Myrick H, Hedden S, Mardikian P, Saladin M, McRae A, Brady K, Kalivas PW, Malcolm R. 2007. Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry 164: 1115-1117.
45. Layer RT, Uretsky NJ, Wallace LJ. 1993. Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Res 617: 267-273.
46. Li YQ, Li FQ, Wang XY, Wu P, Zhao M, Xu CM, Shaham Y, Lu L. 2008. Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. J Neurosci 28: 13248-13257.
47. Li F, Wang XS, Dai RP, Zhang JY, Zhou XF, Hao W, Li CQ. 2011a. The activation of NMDA receptor-ERK pathway in the central amygdala is required for the expression of morphine-conditioned place preference in the rat. Neurotox Res 20: 362-371.
48. Li YQ, Xue YX, He YY, Li FQ, Xue LF, Xu CM, Sacktor TC, Shaham Y, Lu L. 2011b. Inhibition of PKMζ in nucleus accumbens core abolishes long-term drug reward memory. J Neurosci 31: 5436-5446.
49. Li Z, Luan W, Chen Y, Chen M, Dong Y, Lai B, Ma L, Zheng P. 2011c. Chronic morphine treatment switches the effect of dopamine on excitatory synaptic transmission from inhibition to excitation in pyramidal cells of the basolateral amygdala. J Neurosci 31: 17527-17536.
50. Lintas A, Chi N, Lauzon NM, Bishop SF, Gholizadeh S, Sun N, Tan H, LavioletteSR. 2011. Identification of a dopamine receptor-mediated opiate reward memory switch in the basolateral amygdala-nucleus accumbens circuit. J Neurosci 31: 11172-11183.
51. Lu GY, Wu N, Zhang ZL, Ai J, Li J. 2011. Effects of d-cycloserine on extinction and reinstatement of morphine-induced conditioned place preference. Neurosci Lett 503: 196-199.
52. Luo F, Xi ZX, Wu G, Liu C, Gardner EL, Li SJ. 2004. Attenuation of brain response to heroin correlates with the reinstatement of heroin-seeking in rats by fMRI. Neuroimage 22: 1328-1335.
53. Ma YY, Guo CY, Yu P, Lee DY, Han JS, Cui CL. 2006. The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats. Exp Neurol 200: 343-355.
54. Ma YY, Chu NN, Guo CY, Han JS, Cui CL. 2007. NR2B-containing NMDA receptor is required for morphine-but not stress-induced reinstatement. Exp Neurol 203: 309-319.
55. Ma DY, Xu MY, Yang HC, Yang LZ. 2008. Effect of inhibition of the central nucleus of the amygdala and drug experience on the regions underlying footshock-induced reinstatement of morphine seeking. J Int Med Res 36: 992-1000.
56. Ma N, Liu Y, Fu XM, Li N, Wang CX, Zhang H, Qian RB, Xu HS, Hu X, Zhang DR. 2011a. Abnormal brain default-mode network functional connectivity in drug addicts. PLoS ONE 6: e16560.
57. Ma YY, Yu P, Guo CY, Cui CL. 2011b. Effects of ifenprodil on morphine-induced conditioned place preference and spatial learning and memory in rats. Neurochem Res 36: 383-391.
58. Maldonado C, Cauli O, Rodriguez-Arias M, Aguilar MA, Minarro J. 2003. Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal. Behav Brain Res 144: 25-35.
59. Mazei-Robison MS, Nestler EJ. 2012. Opiate-induced molecular and cellular plasticity of ventral tegmental area and locus coeruleus catecholamine neurons. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a012070.
60. McFarland K, Kalivas PW. 2001. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21: 8655-8663.
61. McFarland K, Lapish CC, Kalivas PW. 2003. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23: 3531-3537.
62. McFarland K, Davidge SB, Lapish CC, Kalivas PW. 2004. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci 24: 1551-1560.
63. Moran MM, McFarland K, Melendez RI, Kalivas PW, Seamans JK. 2005. Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci 25: 6389-6393.
64. Morgane PJ, Galler JR, Mokler DJ. 2005. A review of systems and networks of the limbic forebrain/limbic midbrain. Prog Neurobiol 75: 143-160.
65. Moron JA, Gullapalli S, Taylor C, Gupta A, Gomes I, Devi LA. 2010. Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: Conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology 35: 955-966.
66. Myers KM, Carlezon WA Jr. 2010. D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats. Biol Psychiatry 67: 85-87.
67. Nakagawa T, Fujio M, Ozawa T, Minami M, Satoh M. 2005a. Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Behav Brain Res 156: 233-239.
68. Nakagawa T, Yamamoto R, Fujio M, Suzuki Y, Minami M, Satoh M, Kaneko S. 2005b. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Neuroscience 134: 9-19.
69. Narita M, Aoki T, Suzuki T. 2000. Molecular evidence for the involvement of NR2B subunit containing N-methyl-D-aspartate receptors in the development of morphine-induced place preference. Neuroscience 101: 601-606.
70. Narita M, Matsushima Y, Niikura K, Takagi S, Nakahara K, Kurahashi K, Abe M, Saeki M, Asato M, Imai S, et al. 2010. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference. Addict Biol 15: 434-447.
71. Nava F, Caldiroli E, Premi S, Lucchini A. 2006. Relationship between plasma cortisol levels, withdrawal symptoms and craving in abstinent and treated heroin addicts. J Addict Dis 25: 9-16.
72. O'Donnell P, Greene J, Pabello N, Lewis BL, Grace AA. 1999. Modulation of cell firing in the nucleus accumbens. Ann NY Acad Sci 877: 157-175.
73. Olson VG, Zabetian CP, Bolanos CA, Edwards S, Barrot M, Eisch AJ, Hughes T, Self DW, Neve RL, Nestler EJ. 2005. Regulation of drug reward by cAMP response element-binding protein: Evidence for two functionally distinct subregions of the ventral tegmental area. J Neurosci 25: 5553-5562.
74. Papp M, Gruca P, Willner P. 2002. Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist. Neuropsychopharmacology 27: 727-743.
75. Peters J, Kalivas PW. 2006. The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine-and food-seeking behavior in rats. Psychopharmacology (Berl) 186: 143-149.
76. Peters J, LaLumiere RT, Kalivas PW. 2008. Infralimbic prefrontal cortex is responsible for inhibiting cocaine seeking in extinguished rats. J Neurosci 28: 6046-6053.
77. Popik P, Kolasiewicz W. 1999. Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward. Naunyn Schmiedebergs Arch Pharmacol 359: 288-294.
78. Popik P, Wrobel M. 2002. Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology 43: 1210-1217.
79. Popik P, Mamczarz J, Fraczek M, Widla M, Hesselink M, Danysz W. 1998. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. Neuropharmacology 37: 1033-1042.
80. Popik P, Kozela E, Wrobel M, Wozniak KM, Slusher BS. 2003a. Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA. Neuropsychopharmacology 28: 457-467.
81. Popik P, Wrobel M, Rygula R, Bisaga A, Bespalov AY. 2003b. Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice. Behav Pharmacol 14: 237-244.
82. Popik P, Wrobel M, Bisaga A. 2006. Reinstatement of morphine-conditioned reward is blocked by memantine. Neuropsychopharmacology 31: 160-170.
83. Pulvirenti L, Maldonado-Lopez R, Koob GF. 1992. NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat. Brain Res 594: 327-330.
84. Rezayof A, Zarrindast MR, Sahraei H, Haeri-Rohani AH. 2002. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Pharmacol Biochem Behav 74: 187-197.
85. Rezayof A, Zarrindast MR, Sahraei H, Haeri-Rohani A. 2003. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. J Psychopharmacol 17: 415-423.
86. Rezayof A, Golhasani-Keshtan F, Haeri-Rohani A, Zarrindast MR. 2007. Morphine-induced place preference: Involvement of the central amygdala NMDA receptors. Brain Res 1133: 34-41.
87. Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J. 2004. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice. Prog Neuropsychopharmacol Biol Psychiatry 28: 1035-1043.
88. Rizvi TA, Ennis M, Behbehani MM, Shipley MT. 1991. Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: Topography and reciprocity. J Comp Neurol 303: 121-131.
89. Robinson TE, Gorny G, Savage VR, Kolb B. 2002. Widespread but regionally specific effects of experimenter-versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse 46: 271-279.
90. Rogers JL, Ghee S, See RE. 2008. The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse. Neuroscience 151: 579-588.
91. Royer S, Martina M, Pare D. 1999. An inhibitory interface gates impulse traffic between the input and output stations of the amygdala. J Neurosci 19: 10575-10583.
92. Rutten K, Van Der Kam EL, De Vry J, Bruckmann W, Tzschentke TM. 2011. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats. Addict Biol 16: 108-115.
93. See RE. 2009. Dopamine D1 receptor antagonism in the prelimbic cortex blocks the reinstatement of heroin-seeking in an animal model of relapse. Int J Neuropsychopharmacol 12: 431-436.
94. Sekiya Y, Nakagawa T, Ozawa T, Minami M, Satoh M. 2004. Facilitation of morphine withdrawal symptoms and morphine-induced conditioned place preference by a glutamate transporter inhibitor DL-threo-β-benzyloxyaspartate in rats. Eur J Pharmacol 485: 201-210.
95. Sell LA, Morris JS, Bearn J, Frackowiak RS, Friston KJ, Dolan RJ. 2000. Neural responses associated with cue evoked emotional states and heroin in opiate addicts. Drug Alcohol Depend 60: 207-216.
96. Semenova S, Danysz W, Bespalov A. 1999. Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice. Eur J Pharmacol 378: 1-8.
97. Sesack SR, Deutch AY, Roth RH, Bunney BS. 1989. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 290: 213-242.
98. Shabat-Simon M, Levy D, Amir A, Rehavi M, Zangen A. 2008. Dissociation between rewarding and psychomotor effects of opiates: Differential roles for glutamate receptors within anterior and posterior portions of the ventral tegmental area. J Neurosci 28: 8406-8416.
99. Shalev U, Morales M, Hope B, Yap J, Shaham Y. 2001. Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology (Berl) 156: 98-107.
100. Shen H, Moussawi K, Zhou W, Toda S, Kalivas PW. 2011. Heroin relapse requires long-term potentiation-like plasticity mediated by NMDA2b-containing receptors. Proc Natl Acad Sci 108: 19407-19412.
101. Sun N, Chi N, Lauzon N, Bishop S, Tan H, Laviolette SR. 2011. Acquisition, extinction, and recall of opiate reward memory are signaled by dynamic neuronal activity patterns in the prefrontal cortex. Cereb Cortex 21: 2665-2680.
102. Suzuki T, Kato H, Tsuda M, Suzuki H, Misawa M. 1999. Effects of the non-competitive NMDA receptor antagonist ifenprodil on the morphine-induced place preference in mice. Life Sci 64: PL151-PL156.
103. Suzuki T, Kato H, Aoki T, Tsuda M, Narita M, Misawa M. 2000. Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice. Life Sci 67: 383-389.
104. Tahsili-Fahadan P, Carr GV, Harris GC, Aston-Jones G. 2010. Modafinil blocks reinstatement of extinguished opiate-seeking in rats: Mediation by a glutamate mechanism. Neuropsychopharmacology 35: 2203-2210.
105. Ting-A-Kee R, van der Kooy D. 2012. The neurobiology of opiate motiviation. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a012096.
106. Tzschentke TM, Schmidt WJ. 1995. N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett 193: 37-40.
107. Tzschentke TM, Schmidt WJ. 1997. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behav Brain Res 84: 99-107.
108. Tzschentke TM, Schmidt WJ. 1999. Functional heterogeneity of the rat medial prefrontal cortex: Effects of discrete subarea-specific lesions on drug-induced conditioned place preference and behavioural sensitization. Eur J Neurosci 11: 4099-4109.
109. van den Oever MC, Goriounova NA, Li KW, Van der Schors RC, Binnekade R, Schoffelmeer AN, Mansvelder HD, Smit AB, Spijker S, De Vries TJ. 2008. Prefrontal cortex AMPA receptor plasticity is crucial for cue-induced relapse to heroin-seeking. Nat Neurosci 11: 1053-1058.
110. van der Kam EL, de Vry J, Tzschentke TM. 2007. Effect of 2-methyl-6-(phenylethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat. Behav Pharmacol 18: 717-724.
111. van der Kam EL, De Vry J, Tzschentke TM. 2009a. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates ketamine and heroin reward as assessed by acquisition, extinction, and reinstatement of conditioned place preference in the rat. Eur J Pharmacol 606: 94-101.
112. van der Kam EL, De Vry J, Tzschentke TM. 2009b. The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat. Eur J Pharmacol 607: 114-120.
113. Van Strien NM, Cappaert NL, Witter MP. 2009. The anatomy of memory: An interactive overview of the parahippocampal-hippocampal network. Nat Rev Neurosci 10: 272-282.
114. Vargas-Perez H, Ting-A-Kee RA, Heinmiller A, Sturgess JE, van der Kooy D. 2007. A test of the opponent-process theory of motivation using lesions that selectively block morphine reward. Eur J Neurosci 25: 3713-3718.
115. Vargas-Perez H, Ting-A-Kee RA, Walton CH, Hansen DM, Razavi R, Clarke L, Bufalino MR, Allison DW, Steffensen SC, van der Kooy D. 2009. Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats. Science 324: 1732-1734.
116. Veeneman MM, Boleij H, Broekhoven MH, Snoeren EM, Guitart Masip M, Cousijn J, Spooren W, Vanderschuren LJ. 2011. Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine. Psychopharmacology (Berl) 214: 863-876.
117. Watanabe T, Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M. 2002. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol 88: 399-406.
118. Wise RA. 1989. Opiate reward: Sites and substrates. Neurosci Biobehav Rev 13: 129-133.
119. Xi ZX, Stein EA. 2002. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area reduces heroin reinforcement in rat. Psychopharmacology (Berl) 164: 144-150.
120. Xia Y, Portugal GS, Fakira AK, Melyan Z, Neve R, Lee HT, Russo SJ, Liu J, MoronJA. 2011. Hippocampal GluA1-containing AMPA receptors mediate context-dependent sensitization to morphine. J Neurosci 31: 16279-16291.
121. Yonghui L, Xigeng Z, Yunjing B, Xiaoyan Y, Nan S. 2006. Opposite effects of MK-801 on the expression of food and morphine-induced conditioned place preference in rats. J Psychopharmacol 20: 40-46.
122. Zahm DS, Cheng AY, Lee TJ, Ghobadi CW, Schwartz ZM, Geisler S, Parsely KP, Gruber C, Veh RW. 2011. Inputs to the midbrain dopaminergic complex in the rat, with emphasis on extended amygdala-recipient sectors. J Comp Neurol 519: 3159-3188.
123. Zarrindast MR, Rezayof A, Sahraei H, Haeri-Rohani A, Rassouli Y. 2003. Involvement of dopamine D1 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Brain Res 965: 212-221.
124. Zarrindast MR, Lashgari R, Rezayof A, Motamedi F, Nazari-Serenjeh F. 2007. NMDA receptors of dorsal hippocampus are involved in the acquisition, but not in the expression of morphine-induced place preference. Eur J Pharmacol 568: 192-198.
125. Zhou W, Kalivas PW. 2008. N-acetylcysteine reduces extinction responding and induces enduring reductions in cue-and heroin-induced drug-seeking. Biol Psychiatry 63: 338-340.